COPD trials recruiting in Michigan

All COPD trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor, Flint, Southfield
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Farmington Hills, Garden City, Grand Rapids
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female) · Michigan: Dearborn, Flint, Southfield, Troy
• An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
  NCT06035120 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Detroit
• Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
  NCT06891755 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 84 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Allen Park, Detroit, Garden City, Troy
• Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
  NCT05270525 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor, Madison Heights
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Allen Park, Brighton
• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
  NCT07051707 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Detroit
• Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
  NCT04179981 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Michigan: Detroit
• Multi-Center Clean Air Randomized Controlled Trial in COPD
  NCT06376994 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
  NCT02703207 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 89 Years · Sex: All (male and female) · Michigan: Detroit
• SPIROMICS Study of Early COPD Progression (SOURCE)
  NCT05033990 · Phase: Not specified · Ages: 30 Years to 55 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Supporting Evidence-based Responses to Emotional Needs in Emphysema
  NCT06600126 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
  NCT07610395 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Michigan: Dearborn, Troy
• University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
  NCT07482475 · Phase: Not specified · Ages: 50 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor
• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
  NCT07177339 · Phase: Phase 3 · Ages: 40 Years to 75 Years · Sex: All (male and female) · Michigan: Allen Park, Clarkston, Dearborn
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
  NCT05204888 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years and older · Sex: All (male and female) · Michigan: Detroit